MA15.11 Neoadjuvant Sintilimab plus Chemotherapy in EGFR-mutant NSCLC Followed by adjuvant Osimertinib or Observation: A Phase II CTONG2104 Trial
Year: 2024
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: C. Zhang, B-y. Jiang, L-x. Yan, Z-y. Chen, C. Lv, Y-s. Li, S. Dong, R-q. Liao, X-n. Yang, Q. Zhou, Y.-L. Wu, W-z. Zhong
Institution: Guangdong Provincial People's Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4403410311